Inventor

STARCK DOROTHEA

DE17 patents

⚠️ This page may combine multiple inventors who share the name “STARCK DOROTHEA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

STARCK DOROTHEA

ABBOTT LAB

3-substituted 3,4,5,7-tetrahedropyrrolo[3′,4′:4,5]thieno-[2,3-d]pyrimidine derivatives, their preparation and use

Triazole compounds with dopamine-D3-receptor affinity

Triazole compounds with dopamine-D3-receptor affinity

Triazole compounds and the use thereof as dopamine-D3 -ligands

3-Substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use

Triazole compounds with dopamine-D3-receptor affinity

2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-HT1A, 5HT1B and 5-HT1D)

2-{3-[4-(2-t-butyl-6-trifluoromethyl-4-pyrimidinyl)-1- piperazinyl] propylthio}-4-pyrimidinol fumarate

BASF AG

Substituted aza and diazacycloheptane and cyclooctane compounds and their use

3-substituted 3,4-dihydro-thieno[2,3-D]pyrimidine derivatives and production and use of the same

Substituted AZA- and diazacycloheptane and -cyclooctane

Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia

3-substituted pyrido [3&#39;,4&#39;:4,5] Thieno [2,3-d] pyrimidine derivatives, and production and use of the same

ABBOTT GMBH & CO KG

Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Dopamine D3 receptor ligands or antagonists for use in the treatment of renal function disorders

Triazole compounds and the therapeutic use thereof

MÜHLBAUER BERND

Use of dopamine D3 receptor ligands for the production of drugs for treating renal function disorders

3-substituted pyrido [3',4':4,5] Thieno [2,3-d] pyrimidine derivatives, and production and use of the same